Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
When asked CVS Health Company (NYSE:CVS) on CNBC’s “Mad Money Lightning Round.” Jim Kramer said, “I think there is real value here.”
On October 10, Barclays analyst Andrew Mok upgraded CVS Health from Equal-Weight to Overweight and raised the price target from $63 to $82.
Don’t miss:
-
This multi-billion dollar fund has invested in the next big real estate boom, Here’s how you can participate for $10.
This is a paid advertisement. Please consider the Fundrise Flagship Fund’s investment objectives, risks, charges and expenses carefully before investing. You will find this and other information in the The prospectus of the fund. Read them carefully before investing. -
Your biggest return may not come from the stock market. Invest like universities, pension funds and the 1% do. Start investing in commercial real estate today.
Cramer also recommends buying Micron Technology, Inc. (NASDAQ:MU), saying it had a “great” quarter.
On October 8, Keybanc analyst John Vinh maintained Micron Technology with an overweight and lowered the price target from $145 to $135.
Although Cramer believes Old Dominion freight line (NASDAQ:ODFL) will have a good year, but he prefers shares of Pacific Union (NYSE:UNP).
On October 9, Citigroup analyst Ariel Rosa initiated coverage of Old Dominion Freight Line with a neutral rating and announced a price target of $206.
The host of “Mad Money” recommended no touching American tower (NYSE:AMT).
On October 10, Barclays analyst Tim Long maintained an overweight on American Tower and raised the price target from $223 to $255.
Kramer said Howmet Aerospace Inc. (NYSE:HWM) is moving higher, adding that it is one of the biggest stocks of its time.
Howmet Aerospace will announce its third quarter 2024 financial results on Wednesday, November 6.
Trending: A Billion Dollar Investment Strategy with Minimums as Low as $10 – you can be part of the next big real estate boom today.
This is a paid advertisement. Please consider the Fundrise Flagship Fund’s investment objectives, risks, charges and expenses carefully before investing. You will find this and other information in the The prospectus of the fund. Read them carefully before investing.
ADMA biologics (NASDAQ:ADMA) is a “highly speculative” stock, Cramer said.
On September 20, Cantor Fitzgerald analyst Kristen Kluska reiterated ADMA Biologics with an Overweight rating and maintained a $20 price target.
Cramer recommended purchase Modine production (NYSE:MOD). “It’s just one of those great metal bending companies,” he added.
On September 24, DA Davidson analyst Matt Summerville maintained Modine Manufacturing with a buy and raised the price target from $140 to $155.
Robinhood (NASDAQ:HOOD) is a buy, Cramer said.
On October 8, Piper Sandler analyst Patrick Moley left Robinhood with an overweight and maintained a $27 price target.
Wondering if your investments can earn you a $5,000,000 nest egg? Talk to a financial advisor today. SmartAsset’s free tool matches you with up to three vetted financial advisors serving your region, and you can interview your advisors for free to decide which one is right for you.
Keep reading:
This article CVS has ‘real value,’ says Jim Cramer: Micron had a ‘great’ quarter originally appeared on Benzinga.com
